It is therefore hypothesized that estrogen-mediated signaling exerts a protective role in CRC, further understanding of this may benefit cancer prevention and also provide additional therapeutic options for ERβ-positive tumors. The gene discussed is ESR2; the disease is colorectal carcinoma.